Lifeward Expands Access to ReWalk Exoskeleton
In an exciting development for patients with mobility challenges, Lifeward has entered into a new international distribution agreement with Verita Neuro. This collaboration aims to provide access to the ReWalk Personal Exoskeleton in regions that have the potential to make a significant impact on the lives of individuals dealing with spinal cord injuries (SCI).
Partnership with Verita Neuro
Verita Neuro, an established healthcare provider with a strong international presence, will serve as the exclusive distributor of the ReWalk exoskeleton in Mexico, Thailand, and the United Arab Emirates. This partnership enhances Lifeward’s strategy for expanding its commercial footprint globally by leveraging Verita's established network and their expertise in delivering personalized rehabilitation programs.
Transformative Potential
The reach of Verita Neuro is noteworthy, boasting a database of over 25,000 spinal cord injury patients. This valuable resource, combined with their existing network of rehabilitation centers, facilitates a unique opportunity for implementing the ReWalk exoskeleton within their multi-modal treatment methodologies. Verita Neuro aims to integrate advanced treatments including surgical neural stimulation and stem cell therapy into their rehabilitation approach, creating a holistic care model.
Impact on Rehabilitation Practices
Mark Grant, CEO of Lifeward, expressed enthusiasm for this distribution agreement, highlighting that the initiative aligns with Lifeward's ongoing mission to increase global access to life-changing technologies like the ReWalk Personal Exoskeleton. This collaboration embraces a hybrid commercial model that includes direct sales in established markets like the United States, while also engaging partner-led models in select international regions.
Innovative Delivery Methods
This new setup allows for patient-specific training within an intensive, daily, in-patient neurorehabilitation program. Unlike traditional outpatient methods, this progressive approach aims to cultivate a supportive environment for clinical adoption across varying patient profiles and diverse global markets. Lifeward’s innovative framework is designed to enhance the effectiveness of rehabilitation practices, setting a new standard in patient care.
Understanding Lifeward’s Vision
Lifeward’s commitment to transformative healthcare solutions is evident through their diverse portfolio, featuring groundbreaking products such as the ReWalk Exoskeleton, ReStore Exo-Suit, AlterG Anti-Gravity System, and MyoCycle FES System. Founded in 2001, Lifeward has a proven track record of pioneering advancements in the rehabilitation sector, not only in clinical settings but also in the community.
Global Footprint and Future Aspirations
With ongoing operations in the United States, Israel, and Germany, Lifeward continues to push boundaries, striving to empower individuals with physical limitations. Their mission focuses on challenging the conventional rehabilitation landscape and driving innovation that ultimately helps patients regain their independence and improve their quality of life.
Frequently Asked Questions
What is the ReWalk Personal Exoskeleton?
The ReWalk Personal Exoskeleton is a robotic device that enables individuals with spinal cord injuries to stand and walk again, empowering them to regain mobility.
Who is Verita Neuro?
Verita Neuro is a healthcare organization specializing in innovative treatments for spinal cord injuries, brain injuries, and other neurological conditions, with a network of rehabilitation centers.
Where will the ReWalk exoskeleton be distributed?
The ReWalk exoskeleton will be exclusively distributed in Mexico, Thailand, and the United Arab Emirates under the partnership with Verita Neuro.
How does the partnership benefit patients?
This partnership provides patients with access to advanced rehabilitation technologies and personalized care strategies, improving outcomes for spinal cord injury rehabilitation.
What is Lifeward's mission?
Lifeward's mission is to innovate and deliver solutions that transform the lives of individuals with physical limitations, enhancing their capacity to engage in everyday activities.
